% | $
Quotes you view appear here for quick access.

Idenix Pharmaceuticals, AŞ Message Board

  • sonquiqua sonquiqua Apr 8, 2010 8:43 PM Flag

    tyzeka royalties and HCV development

    I wonder if anyone has an idea of the royalty percentage from Tyzeka, which some estimate could sell up to $300 million worldwide. for 2009 it generated only $3 million for idix but I wonder what could be expected in the future.

    The thing I do not understand is how come the team of people that were so successful in the development and launch of Tyzeka were basically fired "to focus on HCV."

    also, I would appreciate any advice you may have on how IDIX compares to competitors in terms of technology and product offering/pipeline (VRTX, VRUS, ACHN, Etc), also considering that the medical community expects a cocktail of drugs will be the way to treat HCV.